Pharmafile Logo
Pharmafocus logo
Advanced Search

Avandia withdrawn in Europe, but remains in US

September 24, 2010
Sales and Marketing Avandia, FDA, pharmacovigilance, safety

GSK’s diabetes drug Avandia is to be withdrawn from the market in Europe because of high levels of heart attack, …

News
Janssen's psoriasis social media campaign

Digital Pharma: Janssen unveils UK social media plans

September 23, 2010
Medical Communications Digital Pharma blog, Facebook, Janssen, Twitter, psoriasis, social media, youtube

Janssen UK is to launch a wide-ranging social media campaign to raise awareness of the chronic skin condition psoriasis. The …

News

Extra phase II studies boost GSK’s Relovair

September 23, 2010
COPD, GlaxoSmithKline, Relovair, asthma

GlaxoSmithKline has conducted additional phase II trials on its asthma/COPD drug Relovair to answer a number of safety and efficacy …

News
Pradaxa

FDA committee backs Pradaxa

September 23, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …

News

Solid results for AstraZeneca’s oral RA drug

September 23, 2010
Research and Development AstraZeneca, Rigel, fostamatinib, rheumatoid arthritis

AstraZeneca’s new oral treatment for rheumatoid arthritis has produced solid results in a phase II trial. Fostamatinib is the first …

News

New Commercial Realities – Part 2: Key stakeholders in the changing healthcare environment

September 23, 2010
Sales and Marketing Kinapse, White paper

Feature
White paper

Lilly names new VP of communications

September 23, 2010
Medical Communications appointment, lilly, medical communications

Jeffrey Winton will next month join Lilly as vice president of communications and take a place on the company’s global …

Appointment

Gilenya approved as new frontline MS treatment

September 22, 2010
Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya

Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …

News

Lixisenatide shaping up to rival Victoza

September 22, 2010
Research and Development Lixisenatide, Sanofi-Aventis, diabetes

Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …

News

Outdated HRT website breaches Code

September 22, 2010
Medical Communications ABPI, Code of Practice, PMCPA, Pfizer, Wyeth

A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …

News

Tesco to sell cut-price Viagra

September 21, 2010
Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra

Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …

News
Blog footer

Digital Pharma: GSK takes drug information to Europe

September 21, 2010
Medical Communications Digital Pharma blog, GlaxoSmithKline, digital patients

European patients can now get information on GlaxoSmithKline’s prescription medicines direct from the company through its expanded health.gsk.com website. The …

News

J&J’s Weldon will appear at next congressional hearing

September 21, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …

News
Vicky_White

Red Door boosts consumer health division

September 21, 2010
Medical Communications Red Door, appointment, medical communications

London-based healthcare communications consultancy Red Door has boosted its consumer health division with two senior appointments. Rachel Vrettos has returned …

Appointment

AAIPharma appoints Patrick Walsh

September 21, 2010
Manufacturing and Production AAIPharma, appointment, manufacturing and production

Contract manufacturing and drug development services company AAIPharma has appointed Patrick Walsh as its new chief executive. Walsh has 30 …

Appointment

Medical, marketing & sales: making cross-functional working work

September 21, 2010
Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives

A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …

Feature

Pharma manufacturing news in brief

September 21, 2010
Manufacturing and Production AAIPharma, Actavis, Japan, KV Pharmaceutical, Purac, Takeda, contract manufacturing

This week’s round-up of pharmaceutical manufacturing news includes updates from Takeda, KV Pharmaceutical, Actavis, AAIPharma and Purac, while Japan’s CMOs …

News

Public sceptical of pharma research

September 21, 2010
Research and Development Animal testing, Animal tests

Businesses including drug companies are seen as broadly untrustworthy or self-serving when it comes to medical research. This is one …

News

Transition drops new diabetes drug

September 20, 2010
Research and Development Transition Therapeutics, diabetes, lilly

Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …

News

FDA launches safety review of Actos

September 20, 2010
Sales and Marketing Actos, Takeda, diabetes

A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026